Corcept Therapeutics Incorporated (CORT) Stock price, Description, News & Info

#ThinkSabio Latest News

Corcept Presents Pivotal Clinical Data in ASCO Late-Breaker with Simultaneous Publication in The Lancet: Relacorilant Improves Progression-Free and Overall Survival in Patients with Platinum-Resistant Ovarian

Light
Dark